Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone-metformin vs Metformin-sulfonylurea on B-cell function in T2DM
NCT00367055Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Oct 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00367055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367055.